Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids

: Oresic M, Hyotylainen T, Kotronen A, Gopalacharyulu P, Nygren H, Arola J, Castillo S, Mattila I, Hakkarainen A, Borra RJH, Honka MJ, Verrijken A, Francque S, Iozzo P, Leivonen M, Jaser N, Juuti A, Sorensen TIA, Nuutila P, Van Gaal L, Yki-Jarvinen H

Publisher: SPRINGER

: 2013

: Diabetologia

: DIABETOLOGIA

: 56

: 10

: 2266

: 2274

: 9

: 0012-186X

DOI: https://doi.org/10.1007/s00125-013-2981-2

The liver-fat-biomarker signature based on molecular lipids may provide a non-invasive tool to diagnose NAFLD, in addition to highlighting lipid molecular pathways involved in the disease.